Dimensional Fund Advisors LP Castle Biosciences Inc Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 999,466 shares of CSTL stock, worth $25.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
999,466
Previous 864,821
15.57%
Holding current value
$25.7 Million
Previous $24.7 Million
7.99%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$78.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$47.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$46.2 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$37 Million0.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il835KShares$21.5 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $677M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...